This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Health Winners & Losers

Inverness Medical Innovations (IMA) launched a smaller health stock on acquisition news, while other stocks in the sector high-stepped through Tuesday on favorable earnings.

Inverness said Tuesday that it's acquiring HemoSense (HEM), which makes handheld blood coagulation monitoring systems for patients taking anticoagulant warfarin, in an all-stock deal. Each share of HemoSense common stock will be reimbursed with 0.274192 shares of Inverness common stock, which the companies said represents a 37.5% premium based on the average trading prices of both companies over the last five trading days.

HemoSense bolted $2.68, or 29%, to $11.95, and Inverness gave up 98 cents, or 2.1%, to $45.46.

In earnings news, biopharmaceutical company Acadia (ACAD - Get Report) reported a net loss of $10.8 million, or 29 cents a share, compared to a loss of $11.9 million, or 43 cents a share, in the year-ago quarter. Analysts surveyed by Thomson Financial had expected a loss of 39 cents a share. Acadia gained $1.31, or 8.7%, to $16.56.

Also, Mentor's (MNT) shares perked up from quarterly earnings supported by robust sales of its MemoryGel breast implants. Shares added $6.27, or 15.3%, to $47.26.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
EPIX $3.00 0.00%
ACAD $32.30 0.00%
THC $31.69 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs